Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty

Martijn Akkerhuis, MJBM (Marcel) van den Brand, C Zwaan, HOJ Peels, H (Harry) Suryapranata, LR van der Wieken, J (Jeanne) Stibbe, J Hoffmann, T Baardman, Jaap Deckers, Maarten Simoons

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
16 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)444-450
Number of pages7
JournalHeart
Volume85
Publication statusPublished - 2001

Research programs

  • EMC 05-01-43-06-03

Cite this